International Stem Cell Corp. (ISCO) Tackles Chronic Liver Disease, a Major Cause of Death
Stem cell technology has unlocked a world of potential treatments for almost every kind of disease. International Stem Cell offers an especially valuable foundation for such treatments through its development of parthenogenetic stem cells (hpSC), non-embryonic histocompatible human stem cells. Parthenogenesis promises to significantly advance the field of regenerative medicine by addressing the problem of immune-rejection. This is because parthenogenesis utilizes unfertilized human eggs to create stem cells that can be immune-matched to millions of people, meaning that a relatively small number of hpSC lines could provide sufficient immune-matched cells to cover a large percentage of the world’s population. ISCO…